Hiv Vaccine Trials Network

This study tested a new HIV vaccine in 38 healthy infants who were exposed to HIV at birth but not infected. The goal was to see if the vaccine is safe and helps the body build defenses against HIV. Researchers measured side effects and immune responses after several doses.

This early-stage study tested two experimental HIV vaccines in 34 healthy, HIV-negative adults to see if they are safe and trigger an immune response. The vaccines use a harmless chimpanzee virus to deliver HIV proteins, followed by a protein boost. The goal is to gather safety d…

This study looked at whether a lab-made antibody called VRC01 could help people with HIV control the virus without taking daily HIV medication. Thirteen people who got HIV during a vaccine study and had been on HIV drugs for at least a year stopped their medication under close mo…

This study enrolled 760 adults who had tested positive for SARS-CoV-2 and recovered. Researchers measured antibodies and immune cells in blood samples over several months to understand how the body remembers the virus. The goal was to improve tests and help design better vaccines…